{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:55:36Z","timestamp":1790708136932,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-468907 and PJT-517882 to JG."],"award-info":[{"award-number":["PJT-468907 and PJT-517882 to JG."]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-26517-9","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T17:25:35Z","timestamp":1764264335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Human MAdCAM-1 antibodies as targeted immune modulators"],"prefix":"10.1038","volume":"15","author":[{"given":"Amanda","family":"Sparkes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther I.","family":"Matus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Diego","family":"Sanchez Vasquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin","family":"Asokumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Gari\u00e9py","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"26517_CR1","doi-asserted-by":"publisher","unstructured":"Eltantawy, N. et al. A review article of inflammatory bowel disease treatment and pharmacogenomics. Beni-Suef Univ. J. Basic Appl. Sci. https:\/\/doi.org\/10.1186\/s43088-023-00361-0 (2023).","DOI":"10.1186\/s43088-023-00361-0"},{"key":"26517_CR2","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1159\/000496739","volume":"37","author":"S Danese","year":"2019","unstructured":"Danese, S. et al. Unmet medical needs in ulcerative colitis: an expert group consensus. Dig. Dis. 37, 266\u2013283 (2019).","journal-title":"Dig. Dis."},{"key":"26517_CR3","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1056\/NEJM200010053431407","volume":"343","author":"UH von Andrian","year":"2000","unstructured":"von Andrian, U. H. & Mackay, C. R. T-Cell function and Migration \u2014 Two sides of the same coin. N. Engl. J. Med. 343, 1020\u20131034 (2000).","journal-title":"N. Engl. J. Med."},{"key":"26517_CR4","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0969-2126(98)00080-X","volume":"6","author":"K Tan","year":"1998","unstructured":"Tan, K. et al. The structure of Immunoglobulin superfamily domains 1 and 2 of MAdCAM-1 reveals novel features important for integrin recognition. Structure 6, 793\u2013801 (1998).","journal-title":"Structure"},{"key":"26517_CR5","unstructured":"Briskin, M. et al. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am. J. Pathol. 151  (1997)."},{"key":"26517_CR6","doi-asserted-by":"crossref","unstructured":"Grant, A. J., Lalor, P. F., H\u00fcbscher, S. G., Briskin, M. & Adams, D. H. MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease). Hepatology 33 (2001).","DOI":"10.1053\/jhep.2001.24231"},{"key":"26517_CR7","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/gut.45.6.856","volume":"45","author":"HS Souza","year":"1999","unstructured":"Souza, H. S., Elia, C. C. S., Spencer, J. & MacDonald, T. T. Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7\/MAdCAM-1 and OX40\/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease. Gut 45, 856\u2013863 (1999).","journal-title":"Gut"},{"key":"26517_CR8","doi-asserted-by":"crossref","unstructured":"Roosenboom, B. et al. Development of Mucosal PNAd\u2009+\u2009and MAdCAM-1\u2009+\u2009Venules during disease course in ulcerative colitis. Cells 9  (2020).","DOI":"10.3390\/cells9040891"},{"key":"26517_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0022-3565(24)38885-8","volume":"295","author":"S Kato","year":"2000","unstructured":"Kato, S. et al. Amelioration of murine experimental colitis by Inhibition of mucosal addressin cell adhesion Molecule-1. J. Pharmacol. Exp. Ther. 295, 183\u2013189 (2000).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"26517_CR10","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.4049\/jimmunol.158.5.2099","volume":"158","author":"D Picarella","year":"1997","unstructured":"Picarella, D. et al. Monoclonal antibodies specific for beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of Scid mice reconstituted with CD45RBhigh CD4\u2009+\u2009T cells. J. Immunol. 158, 2099\u20132106 (1997).","journal-title":"J. Immunol."},{"key":"26517_CR11","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/ecco-jcc\/jjac182","volume":"17","author":"K Uchiyama","year":"2023","unstructured":"Uchiyama, K. et al. Mucosal addressin cell adhesion molecule 1 expression reflects mucosal inflammation and subsequent relapse in patients with ulcerative colitis. J. Crohns Colitis. 17, 786\u2013794 (2023).","journal-title":"J. Crohns Colitis"},{"key":"26517_CR12","doi-asserted-by":"crossref","unstructured":"Ozawa, N. et al. MAdCAM-1 targeting strategy can prevent colitic cancer carcinogenesis and progression via suppression of immune cell infiltration and inflammatory signals. Int. J. Cancer 154  (2024).","DOI":"10.1002\/ijc.34722"},{"key":"26517_CR13","doi-asserted-by":"crossref","unstructured":"De Krijger, M. et al. Expression of MAdCAM-1 and Gut-homing T cells in inflamed pouch mucosa. J. Crohns Colitis 15  (2021).","DOI":"10.1093\/ecco-jcc\/jjab041"},{"key":"26517_CR14","doi-asserted-by":"crossref","unstructured":"Arihiro, S. et al. Differential expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in ulcerative colitis and crohn\u2019s disease. Pathol Int 52  (2002).","DOI":"10.1046\/j.1440-1827.2002.01365.x"},{"key":"26517_CR15","first-page":"756","volume":"13","author":"B Gupta","year":"2024","unstructured":"Gupta, B. et al. Selective targeting of \u03b14\u03b27\/MAdCAM-1 axis suppresses fibrosis progression by reducing Proinflammatory T cell recruitment to the liver. Cells 2024. 13, 756 (2024).","journal-title":"Cells 2024"},{"key":"26517_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1046\/j.1365-2567.1996.d01-727.x","volume":"89","author":"IN Farstad","year":"1996","unstructured":"Farstad, I. N. et al. Distribution of beta 7 integrins in human intestinal mucosa and organized gut-associated lymphoid tissue. Immunology 89, 227\u2013237 (1996).","journal-title":"Immunology"},{"key":"26517_CR17","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1189\/jlb.68.6.807","volume":"68","author":"LS Rott","year":"2000","unstructured":"Rott, L. S., Briskin, M. J. & Butcher, E. C. Expression of \u03b14\u03b27 and E-selectin ligand by Circulating memory B cells: implications for targeted trafficking to mucosal and systemic sites. J. Leukoc. Biol. 68, 807\u2013814 (2000).","journal-title":"J. Leukoc. Biol."},{"key":"26517_CR18","doi-asserted-by":"crossref","unstructured":"Williams, M. B. & Butcher, E. C. Homing of Naive and memory T lymphocyte subsets to peyer\u2019s patches, lymph nodes, and spleen. The J. Immunology 159  (1997).","DOI":"10.4049\/jimmunol.159.4.1746"},{"key":"26517_CR19","doi-asserted-by":"crossref","unstructured":"DeBerg, H. A., Konecny, A. J., Shows, D. M. & Lord, J. D. MAdCAM-1 Costimulates T Cells through Integrin \u03b14\u03b27 to Cause Gene Expression Events Resembling Costimulation through CD28. Immunohorizons 6  (2022).","DOI":"10.4049\/immunohorizons.2200009"},{"key":"26517_CR20","doi-asserted-by":"crossref","unstructured":"Lehnert, K., Print, C. G., Yang, Y. & Krissansen, G. W. MAdCAM-1 costimulates T cell proliferation exclusively through integrin \u03b14\u03b27, whereas VCAM-1 and CS-1 peptide use \u03b14\u03b21: evidence for \u2018remote\u2019 costimulation and induction of hyperresponsiveness to B7 molecules. Eur. J. Immunol 28  (1998).","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3605::AID-IMMU3605>3.3.CO;2-A"},{"key":"26517_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.14309\/ajg.0000000000002485","volume":"119","author":"S Chang","year":"2024","unstructured":"Chang, S., Murphy, M. & Malter, L. A. Review of available medical therapies to treat Moderate-to-Severe inflammatory bowel disease. Am. J. Gastroenterol. 119, 55\u201380 (2024).","journal-title":"Am. J. Gastroenterol."},{"key":"26517_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjad199","author":"S Vermeire","year":"2023","unstructured":"Vermeire, S. et al. Efficacy and safety of the Anti-mucosal addressin cell adhesion Molecule-1 antibody ontamalimab in patients with Moderate-to-Severe ulcerative colitis or crohn\u2019s disease. J. Crohns Colitis. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjad199 (2023).","journal-title":"J. Crohns Colitis"},{"key":"26517_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/cei\/uxad093","volume":"215","author":"AJ Kelly","year":"2024","unstructured":"Kelly, A. J. & Long, A. Targeting T-cell integrins in autoimmune and inflammatory diseases. Clin. Exp. Immunol. 215, 15\u201326 (2024).","journal-title":"Clin. Exp. Immunol."},{"key":"26517_CR24","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/ibd\/izad224","volume":"30","author":"EK Boden","year":"2024","unstructured":"Boden, E. K. et al. Vedolizumab efficacy is associated with decreased intracolonic dendritic cells, not memory T cells. Inflamm. Bowel Dis. 30, 704\u2013717 (2024).","journal-title":"Inflamm. Bowel Dis."},{"key":"26517_CR25","unstructured":"Update of the Financial Impact of the European Commission\u2019s Decision. to Release Takeda from Commitment to Divest Shire\u2019s Pipeline Compound SHP647. https:\/\/www.takeda.com\/newsroom\/statements\/2020\/update-of-the-financial-impact-of-the-european-commissions-decision-to-release-takeda-from-commitment-to-divest-shires-pipeline-compound-shp647\/"},{"key":"26517_CR26","doi-asserted-by":"crossref","unstructured":"Wang, S. H. et al. Integrin \u03b14\u03b27 switches its ligand specificity via distinct conformer-specific activation. J. Cell. Biol. 217  (2018).","DOI":"10.1083\/jcb.201710022"},{"key":"26517_CR27","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/ecco-jcc\/jjx128","volume":"12","author":"G D\u2019Haens","year":"2017","unstructured":"D\u2019Haens, G. et al. Effect of PF-00547659 on central nervous system immune surveillance and Circulating \u03b27\u2009+\u2009T cells in crohn\u2019s disease: report of the TOSCA study. J. Crohns Colitis. 12, 188 (2017).","journal-title":"J. Crohns Colitis"},{"key":"26517_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1074-7613(00)00006-6","volume":"13","author":"JL Xu","year":"2000","unstructured":"Xu, J. L. & Davis, M. M. Diversity in the CDR3 region of V H is sufficient for most antibody specificities. Immunity 13, 37\u201345 (2000).","journal-title":"Immunity"},{"key":"26517_CR29","doi-asserted-by":"crossref","unstructured":"Wang, R., Li, Z., Liu, S. & Zhang, D. Global, regional and National burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: A systematic analysis based on the global burden of disease study 2019. BMJ Open 13  (2023).","DOI":"10.1136\/bmjopen-2022-065186"},{"key":"26517_CR30","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1111\/febs.12829","volume":"281","author":"J Liu","year":"2014","unstructured":"Liu, J. et al. The hydrophobic contacts between the center of the \u03b2I domain and the \u03b11\/\u03b17 helices are crucial for the low-affinity state of integrin \u03b14\u03b27. FEBS J. 281, 2915\u20132926 (2014).","journal-title":"FEBS J."},{"key":"26517_CR31","doi-asserted-by":"crossref","unstructured":"Yuan, M. Y. et al. Mucin-Like domain of mucosal addressin cell adhesion Molecule-1 facilitates integrin \u03b14\u03b27-Mediated cell adhesion through electrostatic repulsion. Front Cell. Dev. Biol 8  (2020).","DOI":"10.3389\/fcell.2020.603148"},{"key":"26517_CR32","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.mucimm.2023.08.001","volume":"16","author":"S Mehandru","year":"2023","unstructured":"Mehandru, S., Colombel, J. F., Juarez, J., Bugni, J. & Lindsay, J. O. Understanding the molecular mechanisms of anti-trafficking therapies and their clinical relevance in inflammatory bowel disease. Mucosal Immunol. 16, 859\u2013870 (2023).","journal-title":"Mucosal Immunol."},{"key":"26517_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-020-01253-8","volume":"20","author":"C Allner","year":"2020","unstructured":"Allner, C. et al. Baseline levels of dynamic CD4\u2009+\u2009T cell adhesion to MAdCAM-1 correlate with clinical response to Vedolizumab treatment in ulcerative colitis: A cohort study. BMC Gastroenterol. 20, 1\u20139 (2020).","journal-title":"BMC Gastroenterol."},{"key":"26517_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.immuni.2007.01.002","volume":"26","author":"R Alon","year":"2007","unstructured":"Alon, R. & Dustin, M. L. Force as a facilitator of integrin conformational changes during leukocyte arrest on blood vessels and Antigen-Presenting cells. Immunity 26, 17\u201327 (2007).","journal-title":"Immunity"},{"key":"26517_CR35","doi-asserted-by":"crossref","unstructured":"Li, J., Yan, J. & Springer, T. A. Low affinity integrin states have faster ligand binding kinetics than the high affinity state: Ligand-interaction kinetics of integrins. Elife 10   (2021).","DOI":"10.7554\/eLife.73359"},{"key":"26517_CR36","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/bph.13654","volume":"174","author":"M Wang","year":"2017","unstructured":"Wang, M. et al. Physiologically relevant binding affinity quantification of monoclonal antibody PF-00547659 to mucosal addressin cell adhesion molecule for in vitro in vivo correlation. Br. J. Pharmacol. 174, 70\u201381 (2017).","journal-title":"Br. J. Pharmacol."},{"key":"26517_CR37","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s41385-018-0044-1","volume":"11","author":"F Nawaz","year":"2018","unstructured":"Nawaz, F. et al. MAdCAM costimulation through Integrin-\u03b14\u03b27 promotes HIV replication. Mucosal Immunol. 11, 1342 (2018).","journal-title":"Mucosal Immunol."},{"key":"26517_CR38","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1189\/jlb.0306231","volume":"81","author":"S Ueha","year":"2007","unstructured":"Ueha, S. et al. Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects. J. Leukoc. Biol. 81, 176\u2013185 (2007).","journal-title":"J. Leukoc. Biol."},{"key":"26517_CR39","doi-asserted-by":"publisher","first-page":"8537","DOI":"10.2147\/IJN.S264513","volume":"15","author":"M Truffi","year":"2020","unstructured":"Truffi, M. et al. Anti-MAdCAM-1-Conjugated nanocarriers delivering quantum Dots enable specific imaging of inflammatory bowel disease. Int. J. Nanomed. 15, 8537\u20138552 (2020).","journal-title":"Int. J. Nanomed."},{"key":"26517_CR40","doi-asserted-by":"crossref","unstructured":"Li, B. et al. Inflammation responsive Tofacitinib loaded albumin nanomedicine for targeted synergistic therapy in ulcerative colitis. Nano Res 16  (2023).","DOI":"10.1007\/s12274-023-5743-6"},{"key":"26517_CR41","doi-asserted-by":"crossref","unstructured":"Sievers, F. et al. Fast, scalable generation of high-quality protein multiple sequence alignments using clustal Omega. Mol. Syst. Biol. 7  (2011).","DOI":"10.1038\/msb.2011.75"},{"key":"26517_CR42","doi-asserted-by":"crossref","unstructured":"Iwata, M. et al. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21 (2004).","DOI":"10.1016\/j.immuni.2004.08.011"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26517-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26517-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26517-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T17:25:40Z","timestamp":1764264340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26517-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["26517"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-26517-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42534"}}